Glycoconjugate Journal

, Volume 16, Issue 7, pp 375–382

A lectin histochemistry comparative study in human normal prostate, benign prostatic hyperplasia, and prostatic carcinoma

  • María I. Arenas
  • Eva Romo
  • Ignacio De Gaspar
  • Fermín R. De Bethencourt
  • Manuel Sánchez-Chapado
  • Benito Fraile
  • Ricardo Paniagua


The partial oligosaccharide sequences of glycoconjugates and the nature of their glycosidic linkages were investigated in normal human prostate, benign prostatic hyperplasia (BPH) and prostatic carcinoma by means of lectin histochemistry, using light microscopy and Western blot analysis. The labeling pattern of BPH differed from that of normal prostate in having more intense staining with DSA, HPA, UEA-I and AAA, and in showing lesser staining with WGA and SBA. Prostatic carcinoma differed from normal prostates in displaying the more intense labeling with PNA, DSA, SBA, DBA, UEA-I and AAA, and in having lesser labeling with WGA. The main differences in labeling pattern between prostatic carcinoma and BPH were that the latter specimens showed more marked staining with PNA, DSA, DBA, SBA, UEA-I and AAA, and lesser staining with WGA and HPA. The staining patterns of SNA, MAA, ConA, LCA and GNA were similar in all three groups of specimens. For most of the lectins studied, including those showing a similar immunohistochemical staining in the three groups of specimens studied, the Western blot analysis showed differences in the banding pattern among normal, hyperplastic, and carcinomatous prostates. Present results suggest that the glycosylation of proteins was modified in both BPH and prostatic carcinoma. In BPH a strong expression of N-acetylgalactosamine residues occurred, while in prostatic carcinoma an increase of sialic aci, galactose and fucose residues was observed. No changes in mannose residues were detected.

lectins Western blot normal prostate benign prostatic hyperplasia prostatic carcinoma 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    McNeal JE (1988) Am J Surg Pathol 12: 619–33.Google Scholar
  2. 2.
    McNeal JE (1969) Cancer 23: 24–34.Google Scholar
  3. 3.
    Blithe DL (1993) Trends Glycosci Glycotechnol 5: 81–9.Google Scholar
  4. 4.
    Sharon N, Lis H (1993) Sci Am 268: 74–81.Google Scholar
  5. 5.
    Zieske JD, Bernstein IA (1982) J Cell Biol 95: 626–31.Google Scholar
  6. 6.
    Mann T, Lutwak-Mann C (1981) In Themes and Trends in Physiology, Biochemistry and Investigative Andrology, pp 269–336. Berlin: Springer Verlag.Google Scholar
  7. 7.
    Janssen T, Petein M, Van Velthoven R, Van Leer P, Fourmarier M, Vanegas JP, Danguy A, Schulman C, Pasteels JL, Kiss R (1996) Hum Pathol 27: 1341–47.Google Scholar
  8. 8.
    Ucci AA, Alroy J, Orgad U, Goyal V, Gavris V (1983) Lab Invest 48: 87–8.Google Scholar
  9. 9.
    Bischof W, Aumuller G (1982) Prostate 3: 507–13.Google Scholar
  10. 10.
    Ghazizadeh M, Kagawa S, Izumi K, Kurokawa K (1984) J Urol 132: 1127–30.Google Scholar
  11. 11.
    Abel PD, Keane P, Leathem A, Tebbutt S, Williams G (1989) Br J Urol 63: 183–85.Google Scholar
  12. 12.
    Drachenberg CB, Papadimitriou JC (1995) Cancer 75: 2539–44.Google Scholar
  13. 13.
    McMahon RF, McWilliam LJ, Mosley S (1992) J Clin Pathol 45: 1094–98.Google Scholar
  14. 14.
    McMahon RF, McWilliam LJ, Clarke NW, George NJR (1994) Br J Urol 74: 80–5.Google Scholar
  15. 15.
    McNeal JE, Leav I, Alroy J, Skutelsky E (1988) Am J Clin Pathol 89: 41–8.Google Scholar
  16. 16.
    Ono K, Katsuyama M, Hotchi M (1983) Stain Technol 58: 309–12.Google Scholar
  17. 17.
    Towbin H, Staehlin T, Gordon J (1979) Proc Natl Acad Sci USA 76: 4350–54.Google Scholar
  18. 18.
    Laemmli UK (1970) Nature 227: 680–85.Google Scholar
  19. 19.
    Loy TS, Kyle J, Bickel JT (1989) Cancer 63: 1583–86.Google Scholar
  20. 20.
    Leathem AJ, Brooks SA (1987) Lancet 9: 1054–56.Google Scholar
  21. 21.
    Shiraishi T, Atsumi S, Yatani R (1992) In Prostate Cancer and Bone Metastasis (Karr JP, Yamanaka H, eds) pp 269–336. New York: Plenum Press.Google Scholar
  22. 22.
    Altevogt P, Fogel M, Cheingsong-Popov R, Dennis J, Roninson P, Schirrmcher V (1983) Cancer Res 43: 5138–44.Google Scholar
  23. 23.
    Hakomori SI (1984) Annu Rev Immunol 2: 103–26.Google Scholar
  24. 24.
    Bohn B, Thies C, Brossmer R (1977) Europ J Cancer 13: 1145–50.Google Scholar
  25. 25.
    McNeal JE, Alroy J, Villers A, Redwine EA, Freiha FS, Stamey TA (1991) Hum Pathol 22: 979–88.Google Scholar
  26. 26.
    Perlman EJ, Epstein JI (1990) Am J Surg Pathol 14: 810–18.Google Scholar
  27. 27.
    Quemener E, Amet Y, Fournier G, Di Stefano S, Abalain JH, Floch HH (1994) Biochem Biophys Res Comm 205: 269–74.Google Scholar

Copyright information

© Kluwer Academic Publishers 1999

Authors and Affiliations

  • María I. Arenas
    • 1
  • Eva Romo
    • 1
  • Ignacio De Gaspar
    • 1
  • Fermín R. De Bethencourt
    • 2
  • Manuel Sánchez-Chapado
    • 2
  • Benito Fraile
    • 1
  • Ricardo Paniagua
    • 1
  1. 1.Department of Cell Biology and GeneticsUniversity of AlcaláMadridSpain
  2. 2.Department of Urology, Hospital Principe de AsturiasMadridSpain

Personalised recommendations